The pharmacological action of kaempferol in central nervous system diseases: a review
J Silva dos Santos, JP Goncalves Cirino… - Frontiers in …, 2021 - frontiersin.org
Kaempferol (KPF) is a flavonoid antioxidant found in fruits and vegetables. Many studies
have described the beneficial effects of dietary KPF in reducing the risk of chronic diseases …
have described the beneficial effects of dietary KPF in reducing the risk of chronic diseases …
A review on Alzheimer's disease pathophysiology and its management: an update
A Kumar, A Singh - Pharmacological reports, 2015 - Elsevier
Alzheimer's disease acknowledged as progressive multifarious neurodegenerative disorder,
is the leading cause of dementia in late adult life. Pathologically it is characterized by …
is the leading cause of dementia in late adult life. Pathologically it is characterized by …
Structure, synthesis, biosynthesis, and activity of the characteristic compounds from Ginkgo biloba L.
XG Liu, X Lu, W Gao, P Li, H Yang - Natural Product Reports, 2022 - pubs.rsc.org
Covering: 1928–2021 Ginkgo biloba L. is one of the most distinctive plants to have emerged
on earth and has no close living relatives. Owing to its phylogenetic divergence from other …
on earth and has no close living relatives. Owing to its phylogenetic divergence from other …
Alzheimer's disease: the challenge of the second century
DM Holtzman, JC Morris, AM Goate - Science translational medicine, 2011 - science.org
Alzheimer's disease (AD) was first described a little more than 100 years ago. It is the most
common cause of dementia with an estimated prevalence of 30 million people worldwide, a …
common cause of dementia with an estimated prevalence of 30 million people worldwide, a …
Combination drug therapy for the management of Alzheimer's disease
MT Kabir, MS Uddin, AA Mamun, P Jeandet… - International Journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Even though the
number of AD patients is rapidly growing, there is no effective treatment for this …
number of AD patients is rapidly growing, there is no effective treatment for this …
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease
SM de la Monte - Current Alzheimer Research, 2012 - ingentaconnect.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer's disease
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder associated
with dementia and cognitive impairment most common in elderly population. Various …
with dementia and cognitive impairment most common in elderly population. Various …
Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease
With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes
an overwhelming health, social, economic, and political problem to nations. Unless a new …
an overwhelming health, social, economic, and political problem to nations. Unless a new …
Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals
TA van Beek, P Montoro - Journal of chromatography A, 2009 - Elsevier
The chemical analysis and quality control of Ginkgo leaves, extracts, phytopharmaceuticals
and some herbal supplements is comprehensively reviewed. The review is an update of a …
and some herbal supplements is comprehensively reviewed. The review is an update of a …
Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease
In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …